Rectal cancer
Development and Validation of a Computer-Based Tool (CDSS) to Help Clinicians Prescribe the Correct Drug Dose in Indian Patients.
Who can joinWomen
Age18+ years
Kind of studyObservational: no new treatment
What it testsWatches and records only
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial CentreNavi Mumbai, MaharashtraDirections ↗
Registry summary (technical)
Development and validation of dosing algorithms for clinical decision support system using a pharmacometric modeling approach in the Indian Population. - NIL
Sponsor: Board of Research in Nuclear Sciences (BRNS)
CTRI/2026/01/101180 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 2 Feb 2026 · read by us 5 Nov 2026